For example, SYK is activated gradually during the progression of alcoholic or viral liver diseases, and therapeutically blocking SYK function by different chemical inhibitors significantly diminished alcohol-induced hepatic steatosis and viral hepatitis [7, 41, 43]. The gene discussed is SYK; the disease is fatty liver disease.